Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ANAB - AnaptysBio, Inc.
-59.3 M
LAST VALUE
-11.13%
2 YEAR CAGR
-4.82%
5 YEAR CAGR
-41.06%
10 YEAR CAGR